File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Phase 1/2 Safety and Antitumor Activity of Nivolumab in Patients With Advanced Hepatocellular Carcinoma: Interim Analysis of the CheckMate 040 Dose-Escalation Study

TitlePhase 1/2 Safety and Antitumor Activity of Nivolumab in Patients With Advanced Hepatocellular Carcinoma: Interim Analysis of the CheckMate 040 Dose-Escalation Study
Authors
El-Khoueiry, ABSangro, BYau, TCCCrocenzi, TSWelling, TH, IIIYeo, WChopra, AAnderson, Jdela Cruz, CLang, LNeely, JMelero, I
Issue Date2016
PublisherS. Karger AG. The Journal's web site is located at http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalHome&ProduktNr=255487
Citation
The 7th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2016): Advancing HCC Management through Multi-Disciplinary Approach, Hong Kong SAR, China, 8-10 July 2016: Abstracts. In Liver Cancer, 2016, v. 5 n. Suppl. 1, p. 52 How to Cite?
DOI: http://dx.doi.org/10.1159/000443566
DescriptionSession 19: Oral Presentation (Basic Science, Hepatology and Oncology): no. 0111
Persistent Identifierhttp://hdl.handle.net/10722/236875
ISSN
2235-1795
2023 Impact Factor: 11.6
2023 SCImago Journal Rankings: 3.599

 

DC FieldValueLanguage
dc.contributor.authorEl-Khoueiry, AB-
dc.contributor.authorSangro, B-
dc.contributor.authorYau, TCC-
dc.contributor.authorCrocenzi, TS-
dc.contributor.authorWelling, TH, III-
dc.contributor.authorYeo, W-
dc.contributor.authorChopra, A-
dc.contributor.authorAnderson, J-
dc.contributor.authordela Cruz, C-
dc.contributor.authorLang, L-
dc.contributor.authorNeely, J-
dc.contributor.authorMelero, I-
dc.date.accessioned2016-12-13T06:48:09Z-
dc.date.available2016-12-13T06:48:09Z-
dc.date.issued2016-
dc.identifier.citationThe 7th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2016): Advancing HCC Management through Multi-Disciplinary Approach, Hong Kong SAR, China, 8-10 July 2016: Abstracts. In Liver Cancer, 2016, v. 5 n. Suppl. 1, p. 52-
dc.identifier.issn2235-1795-
dc.identifier.urihttp://hdl.handle.net/10722/236875-
dc.descriptionSession 19: Oral Presentation (Basic Science, Hepatology and Oncology): no. 0111-
dc.languageeng-
dc.publisherS. Karger AG. The Journal's web site is located at http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalHome&ProduktNr=255487-
dc.relation.ispartofLiver Cancer-
dc.rightsLiver Cancer. Copyright © S. Karger AG.-
dc.titlePhase 1/2 Safety and Antitumor Activity of Nivolumab in Patients With Advanced Hepatocellular Carcinoma: Interim Analysis of the CheckMate 040 Dose-Escalation Study-
dc.typeConference_Paper-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.identifier.doi10.1159/000443566-
dc.identifier.volume5-
dc.identifier.issueSuppl. 1-
dc.identifier.spage52-
dc.identifier.epage52-
dc.publisher.placeSwitzerland-
dc.identifier.issnl1664-5553-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats